Abstract
Insulin-like growth factor-binding proteins (IGFBPs) are important modulators of IGF actions and may have both stimulatory and inhibitory effects. Expression of IGFBP-2 is increased after fasting and in a variety of pathological conditions. However, the specific role of IGFBP-2 in growth physiology remains to be determined. In this review, we summarize data from in vitro and in vivo models suggesting that IGFBP-2 has mainly inhibitory effects on IGF actions. Since the growth hormone (GH)/IGF system is involved in a number of pathological alterations of the kidney and these changes may – at least in part – be due to increased IGF-I, local overexpression of inhibitory IGFBP-2 in the kidney might prevent IGF-I-induced lesions. This hypothesis will be tested by crossing GH transgenic mice, a common model of glomerulosclerosis, with transgenic mice characterized by systemic and renal overexpression of IGFBP-2.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 20 March 1999 / Revised: 16 December 1999 / Accepted: 23 December 1999
Rights and permissions
About this article
Cite this article
Wolf, E., Lahm, H., Wu, M. et al. Effects of IGFBP-2 overexpression in vitro and in vivo. Pediatr Nephrol 14, 572–578 (2000). https://doi.org/10.1007/s004670000362
Issue Date:
DOI: https://doi.org/10.1007/s004670000362